NCT06086587View on ClinicalTrials.gov

Development and Application of Molecular Evaluation Instrument for Lung Cancer Diagnosis and Treatment

Not yet recruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

November 7, 2023

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2025

Conditions

Lung Cancer

All Listed Sponsors

lead

Shanghai Pulmonary Hospital, Shanghai, China

OTHER

NCT06086587 - Development and Application of Molecular Evaluation Instrument for Lung Cancer Diagnosis and Treatment | Biotech Hunter | Biotech Hunter